Latest
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
Latest
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
-
Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2
-
Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich
-
A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.
-
Hyris and its network want to make pragmatic impact Helping Ukrainian Families
-
Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.
-
Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.
-
Hyris and Singlabs signed a distributorship agreement for Singapore
-
Hyris and P.Intertrade Equipments signed a distributorship agreement for Thai market.
-
Hyris to participate to SIBioC 2022 in Genova, presenting Hyris marketplace approach for laboratory medicine
-
Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia
-
Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2
-
Hyris presented Hyris System, its distruptive signature technology, at Analytica 2022 in Munich
-
A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.
-
Hyris and its network want to make pragmatic impact Helping Ukrainian Families
-
Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.
-
Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.